» Articles » PMID: 33091701

The Prevalence of Pulmonary Embolism in Patients with COVID-19 and Respiratory Decline: A Three-setting Comparison

Abstract

Background: The risk of pulmonary embolism (PE) in patients with Coronavirus Disease 2019 (COVID-19) is recognized. The prevalence of PE in patients with respiratory deterioration at the Emergency Department (ED), the regular ward, and the Intensive Care Unit (ICU) are not well-established.

Objectives: We aimed to investigate how often PE was present in individuals with COVID-19 and respiratory deterioration in different settings, and whether or not disease severity as measured by CT-severity score (CTSS) was related to the occurrence of PE.

Patients/methods: Between April 6th and May 3rd, we enrolled 60 consecutive adult patients with confirmed COVID-19 from the ED, regular ward and ICU who met the pre-specified criteria for respiratory deterioration.

Results: A total of 24 (24/60: 40% (95% CI: 28-54%)) patients were diagnosed with PE, of whom 6 were in the ED (6/23: 26% (95% CI: 10-46%)), 8 in the regular ward (8/24: 33% (95% CI: 16-55%)), and 10 in the ICU (10/13: 77% (95% CI: 46-95%)). CTSS (per unit) was not associated with the occurrence of PE (age and sex-adjusted OR 1.06 (95%CI 0.98-1.15)).

Conclusion: The number of PE diagnosis among patients with COVID-19 and respiratory deterioration was high; 26% in the ED, 33% in the regular ward and 77% in the ICU respectively. In our cohort CTSS was not associated with the occurrence of PE. Based on the high number of patients diagnosed with PE among those scanned we recommend a low threshold for performing computed tomography angiography in patients with COVID-19 and respiratory deterioration.

Citing Articles

The Maastricht Intensive Care COVID Cohort: A Critical Appraisal of the Predefined Research Questions.

Wintjens M, Aydeniz E, van Rosmalen F, Driessen R, Hulshof A, Bergmans D Crit Care Explor. 2025; 7(2):e1211.

PMID: 39899442 PMC: 11793260. DOI: 10.1097/CCE.0000000000001211.


Significance of Initial Chest CT Severity Score (CTSS) and Patient Characteristics in Predicting Outcomes in Hospitalized COVID-19 Patients: A Single Center Study.

Milenkovic A, Nikolic S, Elek Z, Aritonovic Pribakovic J, Ilic A, Bulatovic K Viruses. 2024; 16(11).

PMID: 39599799 PMC: 11599031. DOI: 10.3390/v16111683.


Non-Invasive Ventilation Support during Hospitalization for SARS-CoV-2 and the Risk of Venous Thromboembolism.

Siniscalchi C, Ticinesi A, Nouvenne A, Guerra A, Parise A, Finardi L J Clin Med. 2024; 13(10).

PMID: 38792278 PMC: 11122199. DOI: 10.3390/jcm13102737.


A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients.

Othman H, Abdul Halim Zaki I, Isa M, Ming L, Zulkifly H BMC Infect Dis. 2024; 24(1):484.

PMID: 38730292 PMC: 11088167. DOI: 10.1186/s12879-024-09374-1.


The Incidence of Pulmonary Embolism in Hospitalized Non-ICU Patients with COVID-19 during the First Wave: A Multicenter Retrospective Cohort Study in the Netherlands.

Maas A, Wyers C, Dielis A, Barten D, van Kampen V, van der Krieken T J Vasc Res. 2024; 61(3):142-150.

PMID: 38631294 PMC: 11151976. DOI: 10.1159/000538312.


References
1.
Demelo-Rodriguez P, Cervilla-Munoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macias M, Toledo-Samaniego N . Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020; 192:23-26. PMC: 7219400. DOI: 10.1016/j.thromres.2020.05.018. View

2.
Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F . Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020; 383(2):120-128. PMC: 7412750. DOI: 10.1056/NEJMoa2015432. View

3.
Llitjos J, Leclerc M, Chochois C, Monsallier J, Ramakers M, Auvray M . High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020; 18(7):1743-1746. PMC: 7264774. DOI: 10.1111/jth.14869. View

4.
Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020; 191:148-150. PMC: 7192101. DOI: 10.1016/j.thromres.2020.04.041. View

5.
Wolf S, McCubbin T, Feldhaus K, Faragher J, Adcock D . Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med. 2004; 44(5):503-10. DOI: 10.1016/j.annemergmed.2004.04.002. View